Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab plus Rituximab in Previously Untreated Follicular NHL
NCT00553501Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2008
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of epratuzumab in follicular lymphoma (FL), sponsored by Cancer and Leukemia Group B. Started Mar 2008; status: completed.
02
Drugs
epratuzumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00553501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553501.